How Ventavis Helps Patients with PAH* Symptoms (NYHA Class III/IV)
How does Ventavis help treat pulmonary arterial hypertension (PAH)*?
Ventavis is delivered right to the lungsthe site of the disease. Ventavis is an inhaled therapy that can be given alone to help patients walk farther and breathe easier with daily activities. It can also be safely used with many other drugs.†
In clinical studies, Ventavis has been shown to lower high blood pressure and resistance in the pulmonary artery (main blood vessel) leading to the lungs to allow the heart to pump better.1
Patients felt better doing daily activities and improved their NYHA Class.1
- Many patients who felt short of breath (even when sitting still) found that they were able to be more active.
Also, patients were able to walk farther in a timed test.‡1
- Patients who took Ventavis were able to walk farther by at least 10% in a 6-minute walk test. On average, patients who took Ventavis could walk 40 meters farther than those who did not take Ventavis.
Ventavis decreased the worsening of PAH* symptoms.1
- PAH* is a progressive disease, which means it tends to get worse if not treated. Patients who took Ventavis had less worsening of PAH*.
- It's important to remember that each person responds differently to therapy.
Read about:
†Talk to your doctor about the medications you are taking.
‡In a study of 146 patients with NYHA Class III or IV PAH*, researchers compared 2 groups of patients for 12 weeks: 1 group received Ventavis inhaled 6 to 9 times per day, while the other group inhaled placebo (no active medicine). About 5 times as many patients taking Ventavis had clinical improvement compared to those who took placebo during the study (19% vs. 4%).1
